Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
Recent clinical studies highlight advances in intraocular lens (IOL) technology, with enhanced monofocal and extended depth of focus designs delivering improved intermediate and distance vision for ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
Cataract surgery is a once-in-a-lifetime investment in your eyes that can improve your quality of life for the long term. Advanced lens options can reduce or eliminate the need for glasses after your ...
Please provide your email address to receive an email when new articles are posted on . The enVista Aspire IOL was designed to improve depth of focus from distance to intermediate vision. Most eyes ...
Celebrating 75 years of intraocular lens advancements that have improved care for millions of cataract patients. On November 29, 1949, Sir Harold Ridley performed a surgical procedure to replace a ...
Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...
enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia tolerance EyeGility™ delivery system ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide.9,+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results